Mariam Ahmed, Takeda Pharmaceuticals

Mariam Ahmed is a Director and Quantitative Clinical Pharmacology Lead at Takeda Pharmaceuticals and a former FDA clinical pharmacology reviewer. She is the founder and Chair of the ASCPT Rare Disease Community and an editor for the Journal of Clinical Pharmacology, with multiple peer‑reviewed publications focused on advancing drug development in areas of high uncertainty. Across her regulatory and industry roles, she has contributed to the development and regulatory review of numerous rare disease programs, supporting INDs, pediatric development, and NDA/BLA submissions that have informed regulatory decision‑making and approvals.